Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. inflammation cardiovascular
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Inflammation Cardiovascular Articles & Analysis

4 news found

Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

This compound has gained attention for its multifunctional properties and critical role in drug discovery and development.N-Benzylhydroxylamine Hydrochloride features a unique nitrogen–oxygen (N–O) functional group, which enables its wide-ranging applications in medicinal chemistry, including:l Metal Chelation for Iron Overload Disorders: Its ability to form stable complexes with metal ions like ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

CD Formulation's extensive range of APIs can be classified into amino acid series, antibacterial, anti-inflammatory and antiviral series, cardiovascular series, hormone series and other APIs. All these APIs are essential for the development of effective drugs to meet various medical needs. ...

ByCD Formulation


Invizius attracts £2.75m Pre-Series A investment

Invizius attracts £2.75m Pre-Series A investment

Invizius’s technology stems from research by the company’s co-founder and CTO, Dr Andy Herbert, and his team who believe it could reduce the huge death toll from cardiovascular disease among long-term dialysis patients. Currently life expectancy on dialysis is just one-third of normal, and half of patients die from cardiovascular complications. The ...

ByInvizius Limited


Invizius secures £0.5m investment

Invizius secures £0.5m investment

Despite improvements in dialysis therapy, cardiovascular disease remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications, and life expectancy on dialysis is just one-third of that for the general population. The patient’s immune system sees the dialysis filter as a foreign ...

ByInvizius Limited

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT